<html>
  <head>
    <title>Pathways | Routine Pregnancy Care Schedule</title>
  </head>
  <body>
    <h2>Routine Pregnancy Care Schedule</h2>
    <h4><a class='ajax' href='/specializations/22'>Obstetrics Gynecology</a></h4>
    <table class="table">
      <thead>
        <tr class="h1">
          <th width="10%">Week</th>
          <th width="45%">Intervention</th>
          <th width="45%">Notes</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td>0&ndash;14</td>
          <td>Offer genetic screening (SIPS)</td>
          <td>1<sup>st</sup> blood test must be done before 14 weeks. Test for PAPP-A</td>
        </tr>
        <tr>
          <td></td>
          <td>Folic acid 0.4&ndash;5 mg daily</td>
          <td>Risk dependent</td>
        </tr>
        <tr>
          <td></td>
          <td>Offer early U/S to confirm dates</td>
          <td>Between 11&ndash;14 weeks</td>
        </tr>
        <tr>
          <td></td>
          <td>Counsel all women regarding alcohol and tobacco use</td>
          <td>TWEAK questionnaire for alcohol</td>
        </tr>
        <tr>
          <td></td>
          <td>Inactivated vaccines: flu, Hep, DPT if needed</td>
          <td>Avoid live/attenuated vaccines: MMR, Varicella</td>
        </tr>
        <tr>
          <td></td>
          <td>Complete Antenatal Record/Physical</td>
          <td></td>
        </tr>
        <tr>
          <td></td>
          <td>Test: blood group, Rh and RBC antibody, Hb, MCV, HIV, rubella titre, STS, HbsAg, TSH, chlamydia and gonorrhea test, urine C&amp;S</td>
          <td>If indicated: HCV, GTT/FBG, Pap. If exposure – Parvo B19, mumps, toxoplasmosis, CMV</td>
        </tr>
        <tr>
          <td></td>
          <td>Each visit: BP, U/A for proteinuria, weight</td>
          <td>If appropriate: STI screen, SFH, FHR</td>
        </tr>
        <tr>
          <td>15&ndash;17</td>
          <td>Genetic screening (Quad screen)</td>
          <td>2<sup>nd</sup> blood test between 15 and 20 weeks; test for AFP, Estradiol, hCG, and inhibin A</td>
        </tr>
        <tr>
          <td>18&ndash;20</td>
          <td>Offer detailed ultrasound</td>
          <td></td>
        </tr>
        <tr>
          <td>24&ndash;26</td>
          <td>Repeat Rh antibody if Rh negative</td>
          <td></td>
          <td></td>
        </tr>
        <tr>
          <td>24&ndash;28</td>
          <td>Consider GDM screen if risk factors</td>
          <td></td>
        </tr>
        <tr>
          <td>28</td>
          <td>Offer Rh Ig to Rh negative women</td>
          <td>Blood product – consent</td>
        </tr>
        <tr>
          <td>28&ndash;32</td>
          <td>Administer EPDS</td>
          <td>Depression screen</td>
        </tr>
        <tr>
          <td>34</td>
          <td>Assess fetal presentation</td>
          <td>If unsure – get U/S. Consider ECV</td>
        </tr>
        <tr>
          <td>35&ndash;37</td>
          <td>Offer GBS testing</td>
          <td>If pt Pen anaphylaxis, request sensitivities</td>
          <td></td>
        </tr>
        <tr>
          <td>36&ndash;40</td>
          <td>Genital HSV suppression</td>
          <td>If recurrent: Acyclovir 400 tid from week 36 until delivery</td>
          <td></td>
        </tr>
        <tr>
          <td>37&ndash;41</td>
          <td>Review/Discuss GBS results &amp; options</td>
          <td></td>
        </tr>
        <tr>
          <td>&gt; 41</td>
          <td>Induction consideration</td>
          <td></td>
        </tr>
      </tbody>
    </table>
  </body>
</html>
